Report cover image

U.S. Contraceptive Market

Publisher Grand View Research
Published Mar 06, 2026
Length 80 Pages
SKU # GV21085207

Description

U.S. Contraceptive Market Size, Share & Trends Analysis Report By Product (Pills, Intrauterine Devices, Condoms, Vaginal Ring, Subdermal Implants, Injectable), By Region (West, Southeast, Southwest, Northeast, Midwest), And Segment Forecasts, 2026 - 2033

U.S. Contraceptive Market Summary

The U.S. contraceptive market size was valued at USD 8.4 billion in 2025 and is expected to reach USD 12.4 billion by 2033, growing at a CAGR of 4.9% from 2026 to 2033. The increase in the use of modern contraceptives and the rise in awareness among adolescents and young people about sexual health and family planning are key factors driving the U.S. market growth.

Moreover, government programs have led to an increase in access to contraceptives that help prevent unwanted pregnancies in teenagers. The section below outlines key market factors such as research and development and trends shaping the women’s contraceptive health market. It highlights recent product launches, regulatory approvals, public health initiatives, and technological innovations that are expanding contraceptive choices, improving accessibility, and driving market growth in the U.S.

U.S. Contraceptive Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. contraceptive market report based on product and region.
  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Pills
  • Intrauterine Devices (IUD)
  • Hormonal IUD
  • Nonhormonal IUD
  • Condoms
  • Male Condoms
  • Female Condoms
  • Vaginal Ring
  • Subdermal Implants
  • Injectable
  • Others
  • Region Outlook (Revenue, USD Billion, 2021 - 2033)
  • West
  • Southeast
  • Southwest
  • Northeast
  • Midwest
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

80 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Contraceptive Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Product segment outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. U.S. Contraceptive Market: Product Movement Analysis
4.2. U.S. Contraceptive Market: Product Segment Dashboard
4.3. Product Movement & Market Share Analysis, 2024 & 2033
4.4. U.S. Contraceptive Market Estimates & Forecast, by Product
4.5. Pills
4.5.1. Pills Market, 2021 - 2033 (USD Million)
4.6. Intrauterine Devices (IUD)
4.6.1. Intrauterine Devices (IUD) Market, 2021 - 2033 (USD Million)
4.6.2. Hormonal IUD
4.6.2.1. Hormonal IUD market, 2021 - 2033 (USD Million)
4.6.3. Nonhormonal IUD
4.6.3.1. Nonhormonal IUD market, 2021 - 2033 (USD Million)
4.7. Condoms
4.7.1. Condoms Market, 2021 - 2033 (USD Million)
4.7.2. Male Condoms
4.7.2.1. Male condoms market, 2021 - 2033 (USD Million)
4.7.3. Female Condoms
4.7.3.1. Female condoms market, 2021 - 2033 (USD Million)
4.8. Vaginal Ring
4.8.1. Vaginal Ring Market, 2021 - 2033 (USD Million)
4.9. Subdermal Implants
4.9.1. Subdermal Implants Market, 2021 - 2033 (USD Million)
4.10. Injectable
4.10.1. Injectable Market, 2021 - 2033 (USD Million)
4.11. Others
4.11.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Region Business Analysis
5.1. U.S. Contraceptive Market: Region Movement Analysis
5.2. U.S. Contraceptive Market: Region Segment Dashboard
5.3. Region Movement & Market Share Analysis, 2025 & 2033
5.4. U.S. Contraceptive Market Estimates & Forecast, by Region
5.5. West
5.5.1. West Market, 2021 - 2033 (USD Million)
5.6. Southeast
5.6.1. Southeast Market, 2021 - 2033 (USD Million)
5.7. Southwest
5.7.1. Southwest Market, 2021 - 2033 (USD Million)
5.8. Northeast
5.8.1. Northeast Market, 2021 - 2033 (USD Million)
5.9. Midwest
5.9.1. Midwest Market, 2021 - 2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company Categorization
6.2. Company Market Position Analysis, 2025
6.3. Strategy Mapping
6.3.1. Mergers & Acquisitions
6.3.2. Partnership and Collaborations
6.3.3. New Product Launch
6.3.4. Others
6.4. Company Profiles/Listing
6.4.1. Church & Dwight Co., Inc.
6.4.1.1. Overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. Reckitt Benckiser Group Plc
6.4.2.1. Overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. Organon Group of Companies
6.4.3.1. Overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Pfizer, Inc.
6.4.4.1. Overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Teva Pharmaceutical Industries Ltd.
6.4.5.1. Overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. The Cooper Companies, Inc.
6.4.6.1. Overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Mayer Laboratories Inc
6.4.7.1. Overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Agile Therapeutics
6.4.8.1. Overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
6.4.9. Mayne Pharma Group Limited.
6.4.9.1. Overview
6.4.9.2. Financial performance
6.4.9.3. Product benchmarking
6.4.9.4. Strategic initiatives
6.4.10. Bayer AG
6.4.10.1. Overview
6.4.10.2. Financial performance
6.4.10.3. Product benchmarking
6.4.10.4. Strategic initiatives
6.4.11. Afaxys, Inc.
6.4.11.1. Overview
6.4.11.2. Financial performance
6.4.11.3. Product benchmarking
6.4.11.4. Strategic initiatives
6.4.12. AbbVie
6.4.12.1. Overview
6.4.12.2. Financial performance
6.4.12.3. Product benchmarking
6.4.12.4. Strategic initiatives
6.4.13. Gedeon Richter
6.4.13.1. Overview
6.4.13.2. Financial performance
6.4.13.3. Product benchmarking
6.4.13.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us